Reuters logo
BRIEF-Adamas Pharmaceuticals reports Q3 loss per share $1.04
2017年11月2日 / 晚上8点46分 / 18 天前

BRIEF-Adamas Pharmaceuticals reports Q3 loss per share $1.04

Nov 2 (Reuters) - Adamas Pharmaceuticals Inc

* Adamas Pharmaceuticals Inc reports recent achievements and third quarter 2017 financial results

* Q3 loss per share $1.04

* Q3 earnings per share view $-0.98 -- Thomson Reuters I/B/E/S

* Adamas Pharmaceuticals Inc - ‍ expects to receive $65 million in funding from healthcare royalty partners in q4 of 2017

* Adamas Pharmaceuticals Inc - ‍ believe we will be sufficiently capitalized to launch and commercialize gocovri, among others​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below